Literature DB >> 34287620

Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples.

Timothy A Bates1, Hans C Leier1, Zoe L Lyski1, James R Goodman2, Marcel E Curlin3, William B Messer1, Fikadu G Tafesse1.   

Abstract

Entities:  

Year:  2021        PMID: 34287620      PMCID: PMC8295896          DOI: 10.1001/jama.2021.11656

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.

Authors:  David S Khoury; Deborah Cromer; Arnold Reynaldi; Timothy E Schlub; Adam K Wheatley; Jennifer A Juno; Kanta Subbarao; Stephen J Kent; James A Triccas; Miles P Davenport
Journal:  Nat Med       Date:  2021-05-17       Impact factor: 87.241

2.  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

Authors:  Fernando P Polack; Stephen J Thomas; Nicholas Kitchin; Judith Absalon; Alejandra Gurtman; Stephen Lockhart; John L Perez; Gonzalo Pérez Marc; Edson D Moreira; Cristiano Zerbini; Ruth Bailey; Kena A Swanson; Satrajit Roychoudhury; Kenneth Koury; Ping Li; Warren V Kalina; David Cooper; Robert W Frenck; Laura L Hammitt; Özlem Türeci; Haylene Nell; Axel Schaefer; Serhat Ünal; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2020-12-10       Impact factor: 91.245

3.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Authors:  Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

4.  Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.

Authors:  Eric J Haas; Frederick J Angulo; John M McLaughlin; Emilia Anis; Shepherd R Singer; Farid Khan; Nati Brooks; Meir Smaja; Gabriel Mircus; Kaijie Pan; Jo Southern; David L Swerdlow; Luis Jodar; Yeheskel Levy; Sharon Alroy-Preis
Journal:  Lancet       Date:  2021-05-05       Impact factor: 79.321

5.  Excess mortality in England and Wales during the first wave of the COVID-19 pandemic.

Authors:  Evangelos Kontopantelis; Mamas A Mamas; John Deanfield; Miqdad Asaria; Tim Doran
Journal:  J Epidemiol Community Health       Date:  2020-10-15       Impact factor: 3.710

6.  COVID-19 Vaccine Breakthrough Infections Reported to CDC - United States, January 1-April 30, 2021.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-05-28       Impact factor: 17.586

  6 in total
  34 in total

1.  Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients.

Authors:  Zoe L Lyski; Sunny Kim; David Xthona Lee; David Sampson; Hans P Raué; Vikram Raghunathan; Debbie Ryan; Amanda E Brunton; Mark K Slifka; William B Messer; Stephen E Spurgeon
Journal:  medRxiv       Date:  2021-09-07

2.  Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern.

Authors:  Inbal Farkash; Tali Feferman; Noy Cohen-Saban; Yahel Avraham; David Morgenstern; Grace Mayuni; Natasha Barth; Yaniv Lustig; Liron Miller; Dror S Shouval; Asaf Biber; Ilya Kirgner; Yishai Levin; Rony Dahan
Journal:  Cell Rep       Date:  2021-11-24       Impact factor: 9.423

3.  Seroprevalence of Anti-S1-RBD Antibodies in Pre-pandemic and Pandemic Subjects From Hail Region, KSA.

Authors:  Subuhi Sherwani; Mohd Wajid Ali Khan; Arshi Mallik; Mahvish Khan; Mohd Saleem; Mohamed Raafat; Ayed A Shati; Noor Alam
Journal:  Front Public Health       Date:  2022-06-09

4.  The public's attitude to and acceptance of periodic doses of the COVID-19 vaccine: A survey from Jordan.

Authors:  Sawsan Abuhammad; Omar F Khabour; Karem H Alzoubi; Shaher Hamaideh; Baker A Alzoubi; Waed S Telfah; Farah K El-Zubi
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

5.  Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months.

Authors:  Tulio J Lopera; Mateo Chvatal-Medina; Lizdany Flórez-Álvarez; Maria I Zapata-Cardona; Natalia A Taborda; Maria T Rugeles; Juan C Hernandez
Journal:  Front Immunol       Date:  2022-05-02       Impact factor: 8.786

Review 6.  Roadmap for Sex-Responsive Influenza and COVID-19 Vaccine Research in Older Adults.

Authors:  Janna R Shapiro; Rosemary Morgan; Sean X Leng; Sabra L Klein
Journal:  Front Aging       Date:  2022-02-11

Review 7.  Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review.

Authors:  Etsuro Nanishi; Ofer Levy; Al Ozonoff
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 4.526

8.  Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia.

Authors:  Zoe L Lyski; Myung Sun Kim; David Xthona Lee; David Sampson; Hans-Peter Raué; Vikram Raghunathan; Debbie Ryan; Amanda E Brunton; Mark K Slifka; William B Messer; Stephen E Spurgeon
Journal:  Case Rep Hematol       Date:  2022-02-04

9.  Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines.

Authors:  Waleed H Mahallawi; Walaa A Mumena
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

Review 10.  Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease.

Authors:  Seodhna M Lynch; Guangran Guo; David S Gibson; Anthony J Bjourson; Taranjit Singh Rai
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.